Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients

Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients

Introduction: In kidney transplant (KT) recipients diabetes mellitus (DM) are associated with an increased mortality and a poorer graft survival. Glucagon-like peptide 1 receptor agonists (GLP1-RA) have demonstrated cardiovascular and renal benefits in the general population. However, there is lacki...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Alberto Vigara, Florentino Villanego, Cristhian Orellana, Myriam Eady, María Gabriela Sánchez, Marta Alonso, María Belén García, José Manuel Amaro, Teresa García, Auxiliadora Mazuecos
Format: Article
Language:English
Published: Elsevier 2024-11-01
Series:Nefrología (English Edition)
Subjects:
Trasplante renal
Diabetes mellitus
Agonistas del receptor del péptido 1 similar al glucagón
Obesidad
Riesgo cardiovascular
Inmunosupresión
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251424002062
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items